CARGO Therapeutics, Inc. (CRGX)

Profile

Full Name

CARGO Therapeutics, Inc.

Ticker

NASDAQ: CRGX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 13, 2023

Indexes

Not included

Website

https://cargo-tx.com

Employees

167

Key Details

Price

$4.47

Market cap

$216.19M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.72(+77.50% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.47
    CRGX price is $4.47

    30-Day Relative Volume

    0.00
    CRGX 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    CRGX price change on Aug 20, 2025 is unknown

    Price YTD change

    -69%
    CRGX price is down -69% since January 1st

    Price 1-year change

    -73.31%
    CRGX price is down -73.31% year-on-year

    Price 3-year change

    -
    CRGX price 3-year change is unknown

    Price Range

    Price All-time high

    $33.92
    CRGX price is currently -86.82% below its historical high of $33.92

    Price 3-year low

    $3.00
    CRGX price is currently +49.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $216.19M
    CRGX market capitalization is $216.19 million

    Market cap 3-year change

    -
    CRGX market capitalization 3-year change is unknown

    Market cap All-time high

    $1.33B
    CRGX market capitalization is currently -83.72% below its historical high of $1.33 billion

    Market cap sector rank

    52.32%
    CRGX market capitalization is higher than 52.32% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.36%
    CRGX shares outstanding is up +5.36% year-on-year

    Shares Outstanding 3-Year Change

    -
    CRGX shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.77
    CRGX beta is 0.77

    200-day SMA

    $7.72
    CRGX price is currently -42.13% below its 200-day simple moving average

    50-day SMA

    $4.45
    CRGX price is currently +0.56% above its 50-day simple moving average

    RSI

    49.61
    CRGX 14-day relative strength index is 49.61

    Volume

    0.00
    CRGX 30-day relative volume is 0.00

    ATR

    $0.06
    CRGX average true range is $0.06

    10-day Historical Volatility

    13.04%
    CRGX 10-day historical volatility is 13.04%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CRGX annual revenue is $0.00

    Revenue Analysts estimate

    -
    CRGX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CRGX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.72%
    CRGX annual revenue is higher than 28.72% of companies in Healthcare sector

    EPS

    EPS

    -$3.72
    CRGX annual earnings per share is -$3.72

    EPS Analysts estimate

    -$4.71
    CRGX annual earnings per share is currently -21.02% lower than the consensus analysts' forecast

    EPS 1-year change

    +77.5%
    CRGX annual earnings per share is up +77.5% year-on-year

    EPS Sector rank

    24.11%
    CRGX annual earnings per share is higher than 24.11% of companies in Healthcare sector

    Profit

    Gross profit

    -$7.07M
    CRGX annual gross profit is -$7.07 million

    Gross margin

    -
    CRGX annual gross profit margin value is unknown

    Operating profit

    -$187.37M
    CRGX annual operating income is -$187.37 million

    Operating margin

    -
    CRGX annual operating profit margin value is unknown

    Net income

    -$167.50M
    CRGX annual net profit is -$167.50 million

    Net margin

    -
    CRGX annual net profit margin value is unknown

    Expenses

    Total expenses

    $187.37M
    CRGX annual total expenses is $187.37 million

    Operating expenses

    $187.37M
    CRGX annual total operating expenses is $187.37 million

    Cost of goods sold

    $7.07M
    CRGX annual cost of goods sold is $7.07 million

    Selling, general & administrative expenses

    $43.97M
    CRGX annual SGA is $43.97 million

    Depreciation and amortization

    $7.07M
    CRGX annual depreciation & amortization is $7.07 million

    Interest expense

    $0.00
    CRGX annual interest expense is $0.00

    Income tax

    $0.00
    CRGX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$167.50M
    CRGX annual earnings before interest & taxes is -$167.50 million

    EBITDA

    -$160.43M
    CRGX annual EBITDA is -$160.43 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $414.05M
    CRGX annual total assets is $414.05 million

    Non current assets

    $69.04M
    CRGX annual long term assets is $69.04 million

    Current assets

    $345.01M
    CRGX annual total current assets is $345.01 million

    Cash and cash equivalents

    $64.38M
    CRGX annual cash & cash equivalents is $64.38 million

    Accounts receivable

    -
    CRGX annual accounts receivable value is unknown

    Inventory

    $0.00
    CRGX annual inventory is $0.00

    Liabilities

    Total liabilities

    $53.83M
    CRGX annual total liabilities is $53.83 million

    Long term liabilities

    $28.80M
    CRGX annual total long term liabilities is $28.80 million

    Current liabilities

    $25.03M
    CRGX annual total current liabilities is $25.03 million

    Accounts payable

    $2.44M
    CRGX annual accounts payable is $2.44 million

    Debt

    Total debt

    $29.43M
    CRGX annual total debt is $29.43 million

    Total debt 1-year change

    +3.1%
    CRGX annual total debt is up +3.1% year-on-year

    Long term debt

    $28.80M
    CRGX annual long term debt is $28.80 million

    Short term debt

    $628.00K
    CRGX annual short term debt is $628.00 thousand

    Equity & Capital

    Shareholders equity

    $360.23M
    CRGX annual stockholders equity is $360.23 million

    Book value

    $360.23M
    CRGX annual book value is $360.23 million

    Retained earnings

    -$312.65M
    CRGX annual retained earnings is -$312.65 million

    Working capital

    $319.99M
    CRGX annual working capital is $319.99 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$139.74M
    CRGX annual cash flow from operations is -$139.74 million

    Cash from operations 1-year change

    -72.17%
    CRGX annual cash flow from operations is down -72.17% year-on-year

    Cash from investing

    -$305.08M
    CRGX annual cash flow from investing activities is -$305.08 million

    Cash from investing 1-year change

    -3292.78%
    CRGX annual cash flow from investing activities is down -3292.78% year-on-year

    Cash from financing

    $103.47M
    CRGX annual cash flow from financing activities is $103.47 million

    Cash from financing 1-year change

    -79.08%
    CRGX annual cash flow from financing activities is down -79.08% year-on-year

    CAPEX

    CAPEX

    $4.45M
    CRGX annual capital expenditures is $4.45 million

    CAPEX 1-year change

    -46.27%
    CRGX annual capital expenditures is down -46.27% year-on-year

    Free Cash Flow

    Free cash flow

    -$145.14M
    CRGX annual free cash flow is -$145.14 million

    Free cash flow 1-year change

    -60.99%
    CRGX annual free cash flow is down -60.99% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CRGX annual gross profit margin value is unknown

    Operating margin

    -
    CRGX annual operating profit margin value is unknown

    Net margin

    -
    CRGX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -38.64%
    CRGX annual return on assets is -38.64%

    ROE

    -43.76%
    CRGX annual return on equity is -43.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRGX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRGX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.91
    CRGX price to book ratio is 0.91

    PB ratio Sector rank

    33.28%
    CRGX price to book ratio is higher than 33.28% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CRGX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CRGX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$36.37M
    CRGX enterprise value is -$36.37 million

    Enterprise value Sector rank

    3.17%
    CRGX enterprise value is higher than 3.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.26
    CRGX EV/EBITDA is 0.26

    EV/EBITDA Sector rank

    68.73%
    CRGX EV/EBITDA is higher than 68.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    13.79
    CRGX annual current ratio is 13.79

    Quick ratio

    13.79
    CRGX annual quick ratio is 13.79

    Leverage

    Debt to equity

    0.08
    CRGX annual debt to equity ratio is 0.08

    Interest coverage ratio

    -
    CRGX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CRGX piotroski f-score value is unknown

    Altman Z-Score

    0.95
    CRGX altman z-score is 0.95

    Analyst ratings

    Recent major analysts updates

    Jul 8, 25 Jefferies
    Hold
    Jan 30, 25 William Blair
    Market Perform
    Jan 30, 25 Truist Securities
    Hold
    Jan 30, 25 Piper Sandler
    Neutral
    Jan 30, 25 Jefferies
    Hold
    Jan 30, 25 JP Morgan
    Underweight
    Jan 30, 25 HC Wainwright & Co.
    Neutral
    Jan 30, 25 Chardan Capital
    Neutral
    Nov 26, 24 William Blair
    Outperform
    Nov 15, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CRGX included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for CARGO Therapeutics, Inc.?
    • Does CARGO Therapeutics, Inc. pay dividends?
    • What sector is CARGO Therapeutics, Inc. in?
    • What industry is CARGO Therapeutics, Inc. in?
    • What country is CARGO Therapeutics, Inc. based in?
    • When did CARGO Therapeutics, Inc. go public?
    • Is CARGO Therapeutics, Inc. in the S&P 500?
    • Is CARGO Therapeutics, Inc. in the NASDAQ 100?
    • Is CARGO Therapeutics, Inc. in the Dow Jones?
    • When was CARGO Therapeutics, Inc.'s last earnings report?
    • When does CARGO Therapeutics, Inc. report earnings?

    What is the ticker symbol for CARGO Therapeutics, Inc.?

    The ticker symbol for CARGO Therapeutics, Inc. is NASDAQ:CRGX

    Does CARGO Therapeutics, Inc. pay dividends?

    No, CARGO Therapeutics, Inc. does not pay dividends

    What sector is CARGO Therapeutics, Inc. in?

    CARGO Therapeutics, Inc. is in the Healthcare sector

    What industry is CARGO Therapeutics, Inc. in?

    CARGO Therapeutics, Inc. is in the Biotechnology industry

    What country is CARGO Therapeutics, Inc. based in?

    CARGO Therapeutics, Inc. is headquartered in United States

    When did CARGO Therapeutics, Inc. go public?

    CARGO Therapeutics, Inc.'s initial public offering (IPO) was on November 13, 2023

    Is CARGO Therapeutics, Inc. in the S&P 500?

    No, CARGO Therapeutics, Inc. is not included in the S&P 500 index

    Is CARGO Therapeutics, Inc. in the NASDAQ 100?

    No, CARGO Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is CARGO Therapeutics, Inc. in the Dow Jones?

    No, CARGO Therapeutics, Inc. is not included in the Dow Jones index

    When was CARGO Therapeutics, Inc.'s last earnings report?

    CARGO Therapeutics, Inc.'s most recent earnings report was on May 15, 2025

    When does CARGO Therapeutics, Inc. report earnings?

    The next expected earnings date for CARGO Therapeutics, Inc. is November 12, 2025
    On this page